- MetAlert, a developer of personal protective medical equipment and supplies, owes much of its growth to acting on feedback from real-world caregivers who use its products for the monitoring and tracking of vulnerable patients
- This connection with caregivers has yielded advanced products such as the award-winning, multi-patented GPS SmartSole, Invisabelt, Take-Along Tracker, and Rover Tracker, among others
- Attention to consumers has also led to its line of hearing aids, such as its flagship Hear IQ 4 rechargeable, app-controlled hearing aid, and its RoomMate wall-mounted 3D sensors for looking after patients without intruding on their personal space
MetAlert (OTC: MLRT), a developer of personal protective medical equipment and supplies and a pioneer of wearable GPS, human, and asset tracking systems, pays constant and close consideration to feedback from real-world caregivers, and the needs of those who use its products. With over 20 years of experience and an extensive patent portfolio, the company is continually developing viable solutions to individuals afflicted with Alzheimer’s, dementia, and autism (“ADA”), making it one of the few companies that offer practical solutions specific to this group of individuals.
MetAlert is driven by the need to engineer solutions to everyday challenges while maintaining a non-invasive approach to the carrier. This approach has yielded products such as the award-winning, multi-patented GPS SmartSole, the world’s first hidden wearable GPS tracking solution, as well as…
NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
BioMedWire is part of the InvestorBrandNetwork.